Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs

Yoshiki Koizumi, Shingo Iwami

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

In the current era of antiviral drug therapy, combining multiple drugs is a primary approach for improving antiviral effects, reducing the doses of individual drugs, relieving the side effects of strong antiviral drugs, and preventing the emergence of drug-resistant viruses. Although a variety of new drugs have been developed for HIV, HCV and influenza virus, the optimal combinations of multiple drugs are incompletely understood. To optimize the benefits of multi-drugs combinations, we must investigate the interactions between the combined drugs and their target viruses. Mathematical models of viral infection dynamics provide an ideal tool for this purpose. Additionally, whether drug combinations computed by these models are synergistic can be assessed by two prominent drug combination theories, Loewe additivity and Bliss independence. By combining the mathematical modeling of virus dynamics with drug combination theories, we could show the principles by which drug combinations yield a synergistic effect. Here, we describe the theoretical aspects of multi-drugs therapy and discuss their application to antiviral research.

Original languageEnglish
Pages (from-to)41
Number of pages1
JournalTheoretical biology & medical modelling
Volume11
DOIs
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • Modelling and Simulation
  • Health Informatics

Fingerprint Dive into the research topics of 'Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs'. Together they form a unique fingerprint.

Cite this